Skip to main content
Nagoya Journal of Medical Science logoLink to Nagoya Journal of Medical Science
. 2014 Aug;76(3-4):265–272.

CARDIAC COUNTERCLOCKWISE ROTATION IS A RISK FACTOR FOR HIGH-DOSE IRRADIATION TO THE LEFT ANTERIOR DESCENDING CORONARY ARTERY IN PATIENTS WITH LEFT-SIDED BREAST CANCER WHO RECEIVING ADJUVANT RADIOTHERAPY AFTER BREAST-CONSERVING SURGERY

HIDEKAZU TANAKA 1, SHINYA HAYASHI 1, HIROAKI HOSHI 1
PMCID: PMC4345684  PMID: 25741035

ABSTRACT

Patients irradiated for left-sided breast cancer have higher incidence of cardiovascular disease than those receiving irradiation for right-sided breast cancer. Most abnormalities were in the left anterior descending (LAD) coronary artery territory. We analyzed the relationships between preoperative examination results and irradiation dose to the LAD artery in patients with left-sided breast cancer. Seventy-one patients receiving breast radiotherapy were analyzed. The heart may rotate around longitudinal axis, showing either clockwise or counterclockwise rotation (CCWR). On electrocardiography, the transition zone (TZ) was judged in precordial leads. CCWR was considered to be present if TZ was at or to the right of V3. The prescribed dose was 50 Gy in 25 fractions. The maximum (Dmax) and mean (Dmean) doses to the LAD artery and the volumes of the LAD artery receiving at least 20 Gy, 30 Gy and 40 Gy (V20Gy, V30Gy and V40Gy, respectively) were significantly higher in CCWR than in the non-CCWR patients. On multivariate analysis, TZ was significantly associated with Dmax, Dmean, V20Gy, V30Gy, and V40Gy. CCWR is a risk factor for high-dose irradiation to the LAD artery. Electrocardiography is useful for evaluating the cardiovascular risk of high-dose irradiation to the LAD artery.

Key Words: breast cancer, breast-conserving surgery, breast radiotherapy, cardiac toxicity, coronary artery

INTRODUCTION

Most patients with early breast cancer are given breast-conserving treatment, consisting of wide excision and postoperative radiotherapy. Postoperative radiotherapy reduces the risk of local recurrence and results in long-term survival similar to that obtained with mastectomy.1-3)

Breast cancer patients receiving radiotherapy have a 1.27 to 1.76-fold higher mortality rate from cardiac disease than those not given radiotherapy.1,4) Borger et al. reported that patients irradiated for left-sided breast cancer with tangential fields have a higher incidence of cardiovascular disease than those with right-sided cancer.5) The hazard ratio associated with left-sided versus right-sided breast cancer was 1.38 (95% confidence interval, 1.09–2.15). Bouillon et al. reported that patients irradiated for left-sided breast cancer have a 1.56-fold higher mortality from cardiac disease than those given right-sided irradiation.4) Approximately 90% of abnormalities on single photon emission computed tomography myocardial perfusion stress tests or echocardiograms in patients irradiated for left-sided breast cancer were in the left anterior descending (LAD) coronary artery territory.6,7) It would be useful if patients with a high risk of receiving high-dose to the LAD artery could be identified in advance.

Patients underwent various preoperative examinations. If high-risk patients can be identified by these examinations, it would not be necessary to perform additional examinations. This would be advantageous in terms of reducing costs. We analyzed the relationships between preoperative examination results and irradiation dose to the LAD artery in patients with left-sided breast cancer who received tangential radiotherapy.

MATERIALS AND METHODS

Patients and preoperative evaluations

The eligibility criteria of this cross-sectional study were presence of left-sided breast cancer, breast-conserving surgery performed at our institute, no prior thoracic radiotherapy, no prior thoracic surgery, and no underlying diseases, such as interstitial pneumonia or dermatomyositis, contraindicating radiotherapy, written informed consent, in patients without heart disease. Institutional review board approval was waived because this study was a part of routine clinical practice. Written informed consent was obtained from each patient before the radiotherapy. Between February 2007 and October 2013, 71 patients met the criteria. Mammography, contrast-enhanced computed tomography (CT) from chest to pelvis, contrast-enhanced magnetic resonance imaging (MRI) of the breast, breast ultrasound, upright chest X-ray, electrocardiography (ECG), respiratory function tests and blood examinations are routinely performed at our institution to determine the stage and to evaluate whether the patient will be able to undergo surgery under general anesthesia. In the present study, we focus on ECG and CT scout view data.

On ECG, the transition zone (TZ) was judged in precordial leads. The TZ was taken as the point where the R and S waves of 6 precordial leads were of equal amplitude (Fig. 1). Usually, the TZ is at V3 to V4. The heart may rotate around longitudinal axis, showing either clockwise or counterclockwise rotation (CCWR) as viewed from the apex (Fig. 2). CCWR is defined as a TZ at or to the right of V3 according Minnesota Code 9-4-1. Patients were divided into two groups: TZ at or to the right of V3 and TZ at or to the left of V4.

Fig. 1.

Fig. 1

The transition zone (TZ) was taken as the point where the R and S waves of 6 precordial leads were of equal amplitude. This patient’s TZ was at V2

Fig. 2.

Fig. 2

Diagram of counterclockwise rotation of the heart around its longitudinal axis

The cardiothoracic ratio (CTR) was measured in the CT scout view. CTR was defined as: cardiac width/thoracic width × 100 (%). CTR is generally evaluated on upright chest X-rays. However, because our patients were irradiated in the supine position, CTR in the scout view was used. Patients were divided into two groups: CTR ≥ 50 and CTR < 50%.

Body mass index (BMI) was used a physique index. BMI was defined as: weight/(height × height) (kg/m2). The Japanese Society for the Study of Obesity proposed that the standard BMI in Japanese be taken as 22.8) Patients were divided into two groups: BMI ≤ 22 and BMI > 22 kg/m2.

Simulation of radiotherapy planning

Radiopaque markers were placed at the midline, the mid-axillary line, 1 cm below the infra-mammary fold, and at the level of head of the clavicle. All patients were in the supine position on a breast board with both arms above their heads. Images were obtained using a CT scanner with 16 detector arrays (LightSpeed Xtra, GE Healthcare, Waukesha, WI, USA). Patients were scanned with 2.5-mm slices from the clavicle to the mid-abdomen while breathing freely without cardiac gating over 40 seconds. All CT images were transferred to Eclipse External Beam Planning 6.5 (Varian Medical Systems Palo Alto, CA, USA). Two opposed tangential fields were set up according to the clinically determined borders. The reference point was set as the midpoint of the nipple and the posterior border of the field. None of the reference points was on the lung parenchyma or the border between the lung and chest wall. Each patient’s plan was normalized to this reference point. A 6-MV in energy photon beam was used. The prescribed dose was 50 Gy in 25 fractions. Beam weighting and physical wedges were used to achieve the maximum dose to the target ≤ 7% above the prescribed dose, if needed. Corrections for tissue inhomogeneities were used in all cases (Batho power-law method).

The LAD artery was delineated in the anterior interventricular groove down to the apex of the heart with reference to contrast-enhanced CT scans which had been obtained for preoperative evaluation.9) In many cases, the LAD artery was identified non-contrast CT, but in some cases, it was difficult to identify the LAD artery. However, the delineation of the LAD artery is not difficult if anatomical knowledge is applied while observing cranial and caudal slices and contrast-enhanced CT.

Statistical analysis

The dose-volume histogram (DVH) was calculated for each patient. The volumes of the LAD artery receiving at least 20, 30 and 40 Gy (V20Gy, V30Gy and V40Gy, respectively), and the maximum and mean doses (Dmax and Dmean, respectively) of the LAD artery were calculated. Dosimetric parameters were compared using the Mann-Whitney U test. The TZ, CTR, and BMI were estimated employing multiple linear regression analysis. As the TZ is not an interval variable, we created dichotomous categorical variables (TZ at or to the right of V3 and TZ at or to the left of V4). A p value less than 0.05 was considered to indicate a statistically significant difference.

RESULTS

The median age was 55, range 33 to 77, years old. Of the 71 patients, 34 (48%) had a TZ at or to the right of V3. The other 37 (52%) patients had TZ at or to the left of V4. The mean CTR on scout view was 50.9 ± 4.8%. The mean BMI was 22.7 ± 4.2 kg/m2.

The average Dmax, Dmean, V20Gy, V30Gy and V40Gy are shown in Table 1. Dmax, Dmean, V20Gy, V30Gy, and V40Gy were significantly higher in patients with TZ at or to the right of V3 than in those with TZ at or to the left of V4 (p = 0.0002, 0.0002, 0.0017, < 0.0001 and < 0.0001, respectively). There were no statistically significant differences in Dmax, Dmean, V20Gy, V30Gy, or V40Gy between patients with CTR ≥ 50 and those with CTR < 50%. Dmax, V30Gy and V40Gy were significantly higher in patients with BMI ≤ 22 kg/m2 than those with BMI > 22 kg/m2 (p = 0.0008, p = 0.0273 and 0.0034, respectively). There were no statistically significant differences in Dmean, or V20Gy between patients with BMI ≤ 22 and those with BMI > 22 kg/m2.

Table 1.

Dosimetric parameters

TZa CTRb (%) BMIc (kg/m2)
Total At or right of V3 At or left of V4 ≥ 50 < 50 ≤ 22 > 22
Number of patients 71 34 37 41 30 36 35
Maximum dose (Gy) 42.9 46.3e 39.4e 43.9 41.3 45.6f 39.9f
Mean dose (Gy) 16.2 19.6e 12.7e 16.3 16.1 17.9 14.3
V20Gyd (%) 34.4 41.5e 27.1e 35.5 32.6 38.0 30.4
V30Gyd (%) 26.9 35.7e 17.8e 26.8 26.9 31.7f 21.5f
V40Gyd (%) 17.7 26.4e 8.7e 16.9 19.0 23.5f 11.4f

a TZ = transition zone; b CTR = cardiothoracic ratio; c BMI = body mass index;

d V20Gy, V30Gy, and V40Gy = percentage of left anterior descending artery volume receiving ≥ 20, ≥ 30, and ≥ 40 Gy, respectively.

e Significant differences (p < 0.05) between TZ at or right of V3 and at or left of V4.

f Significant differences (p < 0.05) between BMI ≤ 22 and BMI > 22.

On multivariate analysis, TZ and BMI were significantly associated with Dmax, V20Gy and V30Gy. TZ was the only factor associated with Dmean and V40Gy (Table 2).

Table 2.

Summary of multivariate analysis

Regression coefficient Standard error p value Adjusted R2
Maximum dose
  TZa 6.276 1.823 0.0010
  CTRb 0.246 0.198 0.2185 0.221
  BMIc –0.556 0.223 0.0154
Mean dose
  TZa 6.512 1.661 0.0002
  CTRb 0.087 0.180 0.6309 0.219
  BMIc –0.391 0.203 0.0595
V20Gyd
  TZa 13.313 4.069 0.0018
  CTRb 0.456 0.441 0.3054 0.191
  BMIc –1.116 0.498 0.0287
V30Gyd
  TZa 17.066 4.172 0.0001
  CTRb 0.146 0.452 0.7484 0.243
  BMIc –1.115 0.511 0.0329
V40Gyd
  TZa 17.190 4.101 < 0.0001
  CTRb –0.086 0.444 0.8478 0.275
  BMIc –0.973 0.502 0.0572

a TZ = transition zone; b CTR = cardiothoracic ratio; c BMI = body mass index;

d V20Gy, V30Gy, and V40Gy = percentage of left anterior descending artery volume receiving ≥ 20, ≥ 30, and ≥ 40 Gy, respectively.

DISCUSSION

Darby et al. reported that although both mean heart dose and mean LAD coronary artery dose were correlated with the rate of major coronary events, mean heart dose was a better predictor.10) However, the treatment in this report was based on two-dimensional planning. They simulated a treatment plan based on the CT scan of a woman with typical anatomy. Therefore, true individual CT-based radiotherapy information was unavailable for the women studied. The authors noted this as a study limitation. In another article, they reported that it is not known which part of the heart is the most radiosensitive or which structure or structures at risk should be chosen as a reference point for the tolerant dose in clinical practice.11) The use of three-dimensional (3D) planning would elucidate which structure is a better predictor of the risk of major coronary events after long-term patient follow up. Using 3D treatment planning, physicians may be able to decrease the dose delivered to the heart with the use of multileaf collimators to a certain extent depending on the tumor location. Therefore, in this 3D treatment era, the dose delivered to the LAD, which is located the closest to the chest wall, may be more important than that delivered to the entire heart.

The deep inspiration breath-hold (DIBH) technique is one of the methods to reduce the cardiac dose.12-15) Dmax and Dmean to the LAD artery are reportedly reduced approximately 50–60% with the DIBH technique.12,13) DIBH technique is useful for reducing cardiac dose in breast cancer radiotherapy but also in lung cancer radiotherapy.16) This technique is useful, but is highly time-consuming and throughput is thus decreased. Blank reported that technicians were mostly involved during the first irradiation with verification for conventional tangential radiotherapy in free breath and 42 minutes on average. Attendance time of technicians for daily routine treatment without verification was 15 minutes. Occupation time of the accelerator room is the largest in overall room occupation time (42%).17) This study examined tangential breast radiotherapy during free breathing. When the DIBH technique used, the time in the accelerator is longer. While early breast cancer is not uncommon, it may be difficult to irradiate all cases with left-sided breast cancer using the DIBH technique in many institutions. Applying the DIBH technique to high-risk patients is the most realistic approach. If only high-risk patients to be irradiated with the DIBH technique, it is necessary to recognize these patients before performing the planning CT scans for radiotherapy. Patients were scanned while breathing freely for conventional tangential radiotherapy, but were scanned in deep inspiration breath-hold for the DIBH technique.

Taylor CW et al. reported that maximum heart distance (MHD) was correlated with mean heart dose and mean LAD coronary artery dose.18) MHD is the maximum distance between the anterior cardiac contour and the posterior tangential field edges on beam’s eye view. Because measuring MHD is easy, this method is useful. However, the MHD can be measured after the creation of a treatment plan. All patients underwent various examinations preoperatively. If high-risk patients can be identified based on these examinations, there would be no need for additional examinations. This would be advantageous in terms of reducing costs.

The heart may rotate around longitudinal axis, showing either clockwise or counterclockwise rotation as viewed from the apex. The LAD artery of a patient with CCWR is closer to the chest wall than that of a non-CCWR patient. This may cause the LAD artery to receive a higher dose. Dmax, Dmean, V20Gy, V30Gy, and V40Gy were significantly higher in patients with TZ at or to the right of V3 than patients with TZ at or to the left of V4. Because the full length of the LAD artery is near the chest wall in patients with CCWR, doses to this artery were high not only in high-dose region but also moderate-dose region.

Patients with large CTR have large hearts relative to their physiques. If CTR is large, doses to the LAD artery would presumably be high. However, there were no statistically significant differences in Dmax, Dmean, V20Gy, V30Gy, or V40Gy between patients with CTR ≥ 50 and those with CTR < 50%.

Patients with lower BMI were thinner and had little pericardial fat. For patients with large amounts of pericardial fat, this fat tissue provides insulation between the LAD artery and chest wall and increases the distance between the two (Fig. 3). On multivariate analysis, BMI were significantly associated with Dmax, V20Gy and V30Gy. There were marginal significant differences in Dmean and V40Gy between patients with BMI ≤ 22 and those with BMI > 22 kg/m2.

Fig. 3.

Fig. 3

CT images at the level of the cardiac base and apex in a patient whose body mass index (BMI) was 19.1 kg/m2 (3-a, b). CT images at the level of the cardiac base and apex in a patient whose BMI was 27.0 kg/m2 (3-c, d).

This study was limited in that wall motion, respiratory motion, and chest wall deformity were not considered in great detail. However, we believe that we could take into account the average delineation caused by wall and respiratory motion, because the planning CT scan was performed over 40 seconds.

CCWR is a risk factor for high-dose irradiation to the LAD artery and low BMI is an additional risk factor. ECG is useful for evaluating the risk of high-dose irradiation to the LAD artery.

ACKNOWLEDGEMENTS

The authors thank all staff members at division of radiation oncology, Gifu University Hospital for their valuable support. The authors declare that they have no conflict of interest.

REFERENCES

  • 1).Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An review of the randomized trial. Lancet, 2005; 366: 2087–2106. [DOI] [PubMed]
  • 2).Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 2002; 347: 1233–1241. [DOI] [PubMed]
  • 3).Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Rödel C, Souchon R, Wenz F, Sauer R. One life saved by four prevented recurrences? : Update of the early breast cancer trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol, 2012; 188: 461–463. [DOI] [PubMed]
  • 4).Bouillon K, Haddy N, Delaloge S, Garbay JR, Garsi JP, Brindel P, Mousannif A, Lê MG, Labbe M, Arriagada R, Jougla E, Chavaudra J, Diallo I, Rubino C, de Vathaire F. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol, 2011; 57: 445–452. [DOI] [PubMed]
  • 5).Borger JH, Hooning MJ, Boersma LJ, Snijders-Keilholz A, Aleman BM, Lintzen E, van Brussel S, van der Toorn PP< Alwhouhayb M, van Leeuwen FE. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. Int J Raiat Oncol Biol Phys, 2007; 69: 1131–1138. [DOI] [PubMed]
  • 6).Correa CR, Litt HI, Hwang WT, Ferrari VA, Solin LJ, Harris EE. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol, 2007; 25: 3031–3037. [DOI] [PubMed]
  • 7).Correa CR, Das IJ, Litt HI, Ferrari V, Hwang WT, Solin LJ, Harris EE. Association between tangential beam treatment parameters and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Raiat Oncol Biol Phys, 2008; 72: 508–516. [DOI] [PubMed]
  • 8).Matsuzawa Y, Tokunaga K, Kotani K, Keno Y, Kobayashi T, Tarui S. Simple estimation of ideal body weight from body mass index with the lowest morbidity. Diabetes Res Clin Pract, 1990; 10 (Suppl. 1): 159–164. [DOI] [PubMed]
  • 9).Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, Hayman JA, Jagsi R, Jolly S, Larouere J, Soriano J, Marsh R, Pierce LJ. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Raiat Oncol Biol Phys, 2011; 79: 10–18. [DOI] [PMC free article] [PubMed]
  • 10).Darby SC, Ewertz M, McGale P, Bonnet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 2013; 368: 987–998. [DOI] [PubMed]
  • 11).Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ET, Shore RE. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys, 2010; 76: 656–665. [DOI] [PMC free article] [PubMed]
  • 12).Borst GR, Sonke JJ, den Hollander S, Betgen A, Remeijer P, van Giersbergen A, Russel NS, Elkhuizen PH, Bartelink H, van Vliet-Vroegindeweij C. Clinical results of image-guided deep inspiration breath hold breast irradiation. Int J Raiat Oncol Biol Phys, 2010; 78: 1345–1351. [DOI] [PubMed]
  • 13).Vikström J, Hjelstuen MH, Mjaaland I, Dybvik KI. Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol, 2011; 50: 42–50. [DOI] [PubMed]
  • 14).Stranzl H, Zurl B. Postoperative irradiation of left-sided breast cancer patients and cardiac toxicity. Does deep inspiration breath-hold (DIBH) technique protect the heart? Strahlenther Onkol, 2008; 184: 354–358. [DOI] [PubMed]
  • 15).Nemoto K, Oguchi M, Nakajima M, Kozuka T, Nose T, Yamashita T. Cardiac-sparing radiotherapy for the left breast cancer with deep breath-holding. Jpn J Radiol, 2009; 27: 259–263. [DOI] [PubMed]
  • 16).Marchand V, Zefkili S, Desrousseaux J, Simon L, Dauphinot C, Giraud P. Dosimetric comparison of free-breathing and deep inspiration breath-hold radiotherapy for lung cancer. Strahlenther Onkol, 2012; 188: 582–589. [DOI] [PubMed]
  • 17).Blank E, Willich N, Fietkau R, Popp W, Schaller-Steiner J, Sack H, Wenz F. Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial. Strahlenther Onkol, 2012; 188: 113–119. [DOI] [PubMed]
  • 18).Taylor CW, McGale P, Povall JM, Thomas E, Kumar S, Dodwell D, Darby SC. Estimating cardiac exposure from breast cancer radiotherapy in clinical practice. Int J Radiat Oncol Biol Phys, 2009; 73: 1061–1068. [DOI] [PubMed]

Articles from Nagoya Journal of Medical Science are provided here courtesy of Nagoya University School of Medicine/Graduate School of Medicine

RESOURCES